Visit us at booth #541 at ASGCT to learn about our integrated products, manufacturing, and testing to help advance your therapy to patients.
Panel Discussion (30-minutes)
Title: Next Generation Sequencing to characterize encapsidated residual nucleic acids in AAV manufacturing
Presenter: Brad Hasson, Director of Lab Operations for NGS Services
Title: Utilization of DoE for AAV Process Development
Presenter: Michael Shen, PhD, Head of Viral Vector Process Development
1201 S Figueroa St,
Los Angeles, CA, 90015
To continue reading please sign in or create an account.Don't Have An Account?